Immune Therapy for Chronic Lymphocytic Leukemia Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond

被引：7

作者：

Shadman, Mazyar ^{[1
,2
]}

Maloney, David G. ^{[1
,2
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave North,D5-396, Seattle, WA 98109 USA

[2] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 04期

关键词：

CLL; SLL; Allogeneic transplant; CAR-T therapy; Immunotherapy; LONG-TERM OUTCOMES; FOLLOW-UP; COMMITTEE; IBRUTINIB; SOCIETY; BEHALF; BLOOD;

D O I：

10.1016/j.hoc.2021.03.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：847 / 862

页数：16

共 38 条

[1] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations [J].

Ahn, Inhye E. ;

Tian, Xin ;

Wiestner, Adrian .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) :498-500

[2]

Al-Sawaf O, 2020, LANCET ONCOL, V21, P1188, DOI 10.1016/S1470-2045(20)30443-5

[3] Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning [J].

Andersen, Niels Smedegaard ;

Bornhaeuser, Martin ;

Gramatzki, Martin ;

Dreger, Peter ;

Vitek, Antonin ;

Karas, Michal ;

Michallet, Mauricette ;

Moreno, Carol ;

van Gelder, Michel ;

Henseler, Anja ;

de Wreede, Liesbeth C. ;

Schoenland, Stefan ;

Kroeger, Nicolaus ;

Schetelig, Johannes .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) :2823-2834

[4] Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia [J].

Benjamini, Ohad ;

Shimoni, Avichai ;

Besser, Michal ;

Shem-Tov, Noga ;

Danylesko, Ivetta ;

Yerushalmi, Ronit ;

Merkel, Drorit Grizim ;

Tadmor, Tamar ;

Lavie, David ;

Fineman, Riva ;

Jacobi, Elad ;

Nagler, Arnon ;

Avigdor, Abraham .

BLOOD, 2020, 136

[5] Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome [J].

Brown, J. R. ;

Kim, H. T. ;

Armand, P. ;

Cutler, C. ;

Fisher, D. C. ;

Ho, V. ;

Koreth, J. ;

Ritz, J. ;

Wu, C. ;

Antin, J. H. ;

Soiffer, R. J. ;

Gribben, J. G. ;

Alyea, E. P. .

LEUKEMIA, 2013, 27 (02) :362-369

[6] Treatment of Chronic Lymphocytic Leukemia [J].

Burger, Jan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) :460-473

[7] Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab [J].

Byrd, John C. ;

Hillmen, Peter ;

O'Brien, Susan ;

Barrientos, Jacqueline C. ;

Reddy, Nishitha M. ;

Coutre, Steven ;

Tam, Constantine S. ;

Mulligan, Stephen P. ;

Jaeger, Ulrich ;

Barr, Paul M. ;

Furman, Richard R. ;

Kipps, Thomas J. ;

Thornton, Patrick ;

Moreno, Carol ;

Montillo, Marco ;

Pagel, John M. ;

Burger, Jan A. ;

Woyach, Jennifer A. ;

Dai, Sandra ;

Vezan, Remus ;

James, Danelle F. ;

Brown, Jennifer R. .

BLOOD, 2019, 133 (19) :2031-2042

[8] Current Use of and Trends in Hematopoietic Cell Transplantation in the United States [J].

D'Souza, Anita ;

Fretham, Caitrin ;

Lee, Stephanie J. ;

Arora, Mukta ;

Brunner, Janet ;

Chhabra, Saurabh ;

Devine, Steven ;

Eapen, Mary ;

Hamadani, Mehdi ;

Hari, Parameswaran ;

Pasquini, Marcelo C. ;

Perez, Waleska ;

Phelan, Rachel A. ;

Riches, Marcie L. ;

Rizzo, J. Douglas ;

Saber, Wael ;

Shaw, Bronwen E. ;

Spellman, Stephen R. ;

Steinert, Patricia ;

Weisdorf, Daniel J. ;

Horowitz, Mary M. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) :E177-E182

[9] High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies [J].

Dreger, Peter ;

Ghia, Paolo ;

Schetelig, Johannes ;

van Gelder, Michel ;

Kimby, Eva ;

Michallet, Mauricette ;

Moreno, Carol ;

Robak, Tadeusz ;

Stilgenbauer, Stephan ;

Montserrat, Emili .

BLOOD, 2018, 132 (09) :892-902

[10] Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties [J].

Dreger, Peter ;

Michallet, Mauricette ;

Bosman, Paul ;

Dietrich, Sascha ;

Sobh, Mohamad ;

Boumendil, Ariane ;

Nagler, Arnon ;

Scheid, Christof ;

Cornelissen, Jan ;

Niederwieser, Dietger ;

Mueller, Lutz ;

Vandenberghe, Elizabeth ;

Scortechini, Ilaria ;

Schoemans, Helene ;

Andersen, Niels S. ;

Finke, Juergen ;

Russo, Domenico ;

Ljungman, Per ;

Passweg, Jakob ;

van Gelder, Michel ;

Durakovic, Nadira ;

Labussiere-Wallet, Helene ;

Berg, Tobias ;

Wulf, Gerald ;

Bethge, Wolfgang ;

Bunjes, Donald ;

Stilgenbauer, Stefan ;

Canepari, Maria Elisa ;

Schaap, Michel ;

Fox, Christopher P. ;

Kroeger, Nicolaus ;

Montoto, Silvia ;

Schetelig, Johannes .

BONE MARROW TRANSPLANTATION, 2019, 54 (01) :44-52

← 1 2 3 4 →